Skip to main content

Table 3 Association of variables with Candida colonization among pregnant women at Debre Markos Referral hospital, Northwest Ethiopia, May2017

From: Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia

Characteristics

Candida

Crude-OR

(95.0% CI)

Adjusted-OR

(95.0% CI)

Positive

Negative

Total

OR (Lower-Upper)

OR (Lower-Upper)

p-value

18–25

35(18%)

159(82%)

194(50.5%)

1

  

26–33

51(31.1%)

113(68.9%)

164(42.7%)

2.050(1.25–3.35)

1.89(1.02–3.49)

.041

34–40

10(38.5%)

16(61.5%)

26(6.8%)

2.839(1.18–6.78)

2.27(1.01–7.30)

.046

Symptom

 Symptomatic

46(40.5%)

67(59.3%)

113(29.4%)

3.035(1.86–4.92)

2.69(1.60–4.52)

<.001

 Asymptomatic

50(18.7%)

221(81.5%)

271(70.6%)

1

  

antibiotic use

 No

68(21%)

256(79%)

324(84.4)

1

  

 Yes

28(46.7%)

32(53.3)

60(15.6%)

.034 (0.17–0.53)

.393(0.21–0.72)

.003

Contraceptive use

 No

15(12.8%)

102(87.2%)

117(30.5%)

1

  

 Yes

81(30.3%)

186(69.7%)

267(69.5%)

.338 (0.18–61)

.394(0.20–0.74)

.004

Gravidity

 Primigravida

36(20.1%)

143(79.9%)

179(46.6%)

1

  

 Multigravida

60(29.3%)

145(70.7%)

205(53.4%)

.608(0.37–0.97)

.909(0.49–1.67)

.758

HIV status

 Negative

82(23.8%)

262(76.2%)

344(89.6%)

1

  

 Positive

14(35%)

26(65%)

40(10.4%)

1.720(.85–3.44)

.629(.54–2.71)

.629

Gestational period

 1st trimester

9(23.1%)

30(76.9%)

39(10.2%)

1

  

 2nd trimester

32(23.7%)

103(76.3%)

135(35.2%)

1.036(.44–2.40)

.937(.37–2.35)

.890

 3rd trimester

55(26.2%)

155(75%)

210(54.7%)

1.183(.52–2.64)

1.040(.43–2.50)

.930